Skip to main navigation Skip to search Skip to main content

Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants

  • Sayaka Kayumi
  • , Luis A. Pérez-Jurado
  • , María Palomares
  • , Sneha Rangu
  • , Sarah E. Sheppard
  • , Wendy K. Chung
  • , Michael C. Kruer
  • , Mira Kharbanda
  • , David J. Amor
  • , George McGillivray
  • , Julie S. Cohen
  • , Sixto García-Miñaúr
  • , Clare L. van Eyk
  • , Kelly Harper
  • , Lachlan A. Jolly
  • , Dani L. Webber
  • , Christopher P. Barnett
  • , Fernando Santos-Simarro
  • , Marta Pacio-Míguez
  • , Angela del Pozo
  • Somayeh Bakhtiari, Matthew Deardorff, Holly A. Dubbs, Kosuke Izumi, Katheryn Grand, Christopher Gray, Paul R. Mark, Elizabeth J. Bhoj, Dong Li, Xilma R. Ortiz-Gonzalez, Beth Keena, Elaine H. Zackai, Ethan M. Goldberg, Guiomar Perez de Nanclares, Arrate Pereda, Isabel Llano-Rivas, Ignacio Arroyo, María Ángeles Fernández-Cuesta, Christel Thauvin-Robinet, Laurence Faivre, Aurore Garde, Benoit Mazel, Ange Line Bruel, Michael L. Tress, Eva Brilstra, Amena Smith Fine, Kylie E. Crompton, Alexander P.A. Stegmann, Margje Sinnema, Servi C.J. Stevens, Joost Nicolai, Gaetan Lesca, Laurence Lion-François, Damien Haye, Nicolas Chatron, Amelie Piton, Mathilde Nizon, Benjamin Cogne, Siddharth Srivastava, Jennifer Bassetti, Candace Muss, Karen W. Gripp, Rebecca A. Procopio, Francisca Millan, Michelle M. Morrow, Melissa Assaf, Andres Moreno-De-Luca, Shelagh Joss, Mark J. Hamilton, Marta Bertoli, Nicola Foulds, Shane McKee, Alastair H. MacLennan, Jozef Gecz, Mark A. Corbett
  • University of Adelaide
  • Hospital del Mar
  • Pompeu Fabra University
  • Universidad Autónoma de Madrid
  • Yeshiva University
  • The Children's Hospital of Philadelphia
  • National Institutes of Health
  • Columbia University
  • Phoenix Children's Hospital
  • University of Arizona
  • University Hospital Southampton NHS Foundation Trust
  • University of Melbourne
  • Murdoch Children's Research Institute
  • Kennedy Krieger Institute
  • Johns Hopkins University
  • Women's and Children's Hospital Adelaide
  • University of Southern California
  • University of Pennsylvania
  • Cedars-Sinai Medical Center
  • Spectrum Health
  • Hospital Universitario Araba
  • Hospital de Cruces
  • Hospital San Pedro de Alcántara
  • Hospital de Basurto
  • Université de Bourgogne
  • INSERM – Bourgogne Franche-Comté University
  • Spanish National Cancer Research Center
  • Utrecht University
  • Maastricht University
  • Hospices civils de Lyon
  • Université de Strasbourg
  • CHU de Nantes
  • Harvard University
  • Cornell University
  • Alfred I. duPont Hospital for Children
  • Wills Eye Hospital
  • OPKO Health, Inc.
  • Banner Children's Specialists Neurology Clinic
  • Genomic Medicine Institute
  • West of Scotland Clinical Genetics Service
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Northern Ireland Regional Genetics Centre
  • South Australian Health And Medical Research Institute

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

Purpose: Germline loss-of-function variants in CTNNB1 cause neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV; OMIM 615075) and are the most frequent, recurrent monogenic cause of cerebral palsy (CP). We investigated the range of clinical phenotypes owing to disruptions of CTNNB1 to determine the association between NEDSDV and CP. Methods: Genetic information from 404 individuals with collectively 392 pathogenic CTNNB1 variants were ascertained for the study. From these, detailed phenotypes for 52 previously unpublished individuals were collected and combined with 68 previously published individuals with comparable clinical information. The functional effects of selected CTNNB1 missense variants were assessed using TOPFlash assay. Results: The phenotypes associated with pathogenic CTNNB1 variants were similar. A diagnosis of CP was not significantly associated with any set of traits that defined a specific phenotypic subgroup, indicating that CP is not additional to NEDSDV. Two CTNNB1 missense variants were dominant negative regulators of WNT signaling, highlighting the utility of the TOPFlash assay to functionally assess variants. Conclusion: NEDSDV is a clinically homogeneous disorder irrespective of initial clinical diagnoses, including CP, or entry points for genetic testing.

Original languageEnglish
Pages (from-to)2351-2366
Number of pages16
JournalGenetics in Medicine
Volume24
Issue number11
DOIs
StatePublished - Nov 2022

Keywords

  • Autism
  • Cerebral palsy
  • Familial exudative vitreoretinopathy
  • Microcephaly
  • Wnt beta catenin signaling pathway

Fingerprint

Dive into the research topics of 'Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants'. Together they form a unique fingerprint.

Cite this